Directory

New on the Specialities List

The 60 most recent admissions to the Specialities List, from 01/05/2026 to 01/09/2026. The FOPH publishes admissions, changes and deletions monthly, normally effective on the first day of a month. This list shows the most recent admission dates in the current data set.

60 preparationsAs of 17/09/2026

Sorted by the earliest SL admission date among a preparation's packs. A new admission can also be a new pack size of an existing preparation.

New on the Specialities List
PreparationAuthorisation holderDateTypePublic price fromLimitation
Apremilast AccordAccord Healthcare AG01/09/2026GenericCHF 131.05Yes
BCG-medacLabatec Pharma SA01/09/2026Originator productCHF 158.15Yes
Comirnaty XFGPfizer AG01/09/2026Originator productCHF 75.15Yes
Elocom (PI-Eurim)EurimPharm Swiss AG01/09/2026Originator productCHF 13.80No
EzmeklyMerck (Schweiz) AG01/09/2026Originator productCHF 5'157.15Yes
Febuxostat Spirig HCSpirig HealthCare AG01/09/2026GenericCHF 27.60Yes
FluarixGlaxoSmithKline AG01/09/2026Originator productCHF 26.60Yes
Fluco axapharmaxapharm ag01/09/2026GenericCHF 14.45No
InfluvacViatris Pharma GmbH01/09/2026Originator productCHF 26.85Yes
IxifiPfizer AG01/09/2026BiosimilarCHF 554.75Yes
Progesterone BesinsVifor (International) Inc.01/09/2026GenericCHF 13.65No
Rosuvastax-DrossapharmDrossapharm AG01/09/2026GenericCHF 16.95Yes
RyaltrisNOBEL Pharma Schweiz AG01/09/2026Originator productCHF 30.80No
Sitagliptin DevatisDevatis AG01/09/2026GenericCHF 30.95Yes
Solifenacin LemanLeman SKL SA01/09/2026GenericCHF 32.80No
Spikevax XFGModerna Switzerland GmbH01/09/2026Originator productCHF 80.00Yes
Teriflunomid AccordAccord Healthcare AG01/09/2026GenericCHF 414.80No
TestoneDermapharm AG01/09/2026GenericCHF 70.35Yes
Visanne (PI-Eurim)EurimPharm Swiss AG01/09/2026Originator productCHF 63.55No
Eltrombopag DevatisDevatis AG01/08/2026GenericCHF 91.25Yes
EnflonsiaMSD Merck Sharp & Dohme AG01/08/2026Originator productCHF 354.60Yes
FlixabiSamsung Bioepis CH GmbH01/08/2026BiosimilarCHF 554.75Yes
Lorazepam LemanLeman SKL SA01/08/2026GenericCHF 11.20Yes
LysodrenEffRx Pharmaceuticals SA01/08/2026Originator productCHF 681.10No
MynzepliAdvanz Pharma Specialty Medicine Switzerland GmbH01/08/2026BiosimilarCHF 478.45Yes
ObodenceSamsung Bioepis CH GmbH01/08/2026BiosimilarCHF 185.05Yes
RivasurZambon Switzerland Ltd01/08/2026Originator productCHF 51.55Yes
Saphnelo FertpenAstraZeneca AG01/08/2026Originator productCHF 259.95Yes
Trospium Spirig HCSpirig HealthCare AG01/08/2026GenericCHF 15.10No
XbrykSamsung Bioepis CH GmbH01/08/2026BiosimilarCHF 210.45Yes
Chlortalidon GalepharmGalepharm AG01/07/2026Originator productCHF 12.95Yes
Docetaxel ProvectisProvectis Healthcare AG01/07/2026GenericCHF 68.50No
Forsteo (PI-Eurim)EurimPharm Swiss AG01/07/2026Originator productCHF 264.75Yes
JubereqAccord Healthcare AG01/07/2026BiosimilarCHF 210.45Yes
Nasonex (PI-Eurim) Dosier NasensprayEurimPharm Swiss AG01/07/2026Originator productCHF 16.90No
OsvyrtiAccord Healthcare AG01/07/2026BiosimilarCHF 206.10Yes
Paclitaxel-Albumin AccordAccord Healthcare AG01/07/2026GenericCHF 210.20Yes
Silodosin Spirig HCSpirig HealthCare AG01/07/2026GenericCHF 26.20No
Silodosin ZentivaHelvepharm AG01/07/2026GenericCHF 26.20No
YesintekMedius AG01/07/2026BiosimilarCHF 1'252.65Yes
DemilosEffik SA01/06/2026Originator productCHF 16.20Yes
Gabapentin-Mepha TevaMepha Pharma AG01/06/2026GenericCHF 16.35No
JaypircaEli Lilly (Suisse) SA01/06/2026Originator productCHF 2'173.50Yes
Lidocain LemanLeman SKL SA01/06/2026Originator productCHF 13.80No
ObgemsaPierre Fabre Pharma AG01/06/2026Originator productCHF 49.75No
Pramipexol Spirig HC retardSpirig HealthCare AG01/06/2026GenericCHF 14.15Yes
Prucaloprid Spirig HCSpirig HealthCare AG01/06/2026GenericCHF 48.50Yes
Viread (PI-Eurim)EurimPharm Swiss AG01/06/2026Originator productCHF 286.70No
Amlo axapharmaxapharm ag01/05/2026GenericCHF 17.05No
Budesonid-MephaMepha Pharma AG01/05/2026GenericCHF 58.90No
CellCept (PI-Eurim)EurimPharm Swiss AG01/05/2026Originator productCHF 100.40No
Clopido axapharmaxapharm ag01/05/2026GenericCHF 35.10No
Esomeprazol LabatecLabatec Pharma SA01/05/2026GenericCHF 13.75No
EvfraxyMedius AG01/05/2026BiosimilarCHF 206.10Yes
ImuldosaAccord Healthcare AG01/05/2026BiosimilarCHF 1'252.65Yes
Plavix (PI-Eurim)EurimPharm Swiss AG01/05/2026Originator productCHF 32.20No
PyzchivaSamsung Bioepis CH GmbH01/05/2026BiosimilarCHF 1'540.15Yes
Resotranb.e.imaging.ag01/05/2026Originator productCHF 321.05Yes
SteqeymaiQone Healthcare Switzerland SA01/05/2026BiosimilarCHF 1'540.15Yes
Tadalafil PAH DevatisDevatis AG01/05/2026GenericCHF 406.15Yes

Admissions per month

The FOPH bundles admissions onto the first of a month. The distribution shows how uneven publications are: January and July historically carry the largest tranches, because price reduction rounds and indication extensions coincide there.

Admissions per month
MonthAdmissions 
2026-0919
2026-0811
2026-0710
2026-068
2026-0512

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Request a market access callView information

New on the SL: FAQ

When do new SL admissions take effect?

The FOPH publishes the Specialities List monthly. Admissions, price changes and removals normally take effect on the first day of a month. The ruling reaches the authorisation holder earlier; the date in the publication is what binds.

How long does it take from authorisation to SL admission?

If the holder files within 60 days of Swissmedic authorisation, the FOPH in principle decides within 60 days of receiving the complete dossier (Art. 31b of the Health Care Benefits Ordinance). In practice four to nine months often pass between authorisation and publication, because of price negotiations and commission meeting dates.

Why is a newly authorised medicine not listed yet?

Because admission is a separate FOPH procedure. With no admission request, during a price negotiation or after a rejection, the preparation stays authorised but is not reimbursed. Until then only individual case reimbursement under Art. 71a-d of the Health Insurance Ordinance or private payment is available.

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Request a market access callView information
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com